Americans increasingly trust career scientists at federal health agencies more than the political leaders running those agencies, according to a new survey from the Annenberg Public Policy Center at the University of Pennsylvania. This finding highlights a growing divide in how the public views scientific expertise versus government leadership, particularly as trust in public health officials has continued to decline since the pandemic. What Does the Survey Actually Show About Public Trust? The Annenberg Center survey reveals a striking pattern in how Americans view their health institutions. While confidence in career scientists at federal health agencies remains relatively strong, trust in the agencies' political leaders has fallen significantly. This gap is particularly notable given that public trust in Health and Human Services (HHS) agencies already took a major hit during the pandemic and has continued to decline since then. The survey also found that Americans place even higher trust in outside professional health organizations than they do in government entities. Organizations like the American Heart Association and the American Academy of Pediatrics rank higher in public confidence than any federal health agency or their leaders. This suggests that the public is actively seeking health information and guidance from sources they perceive as more independent and credible. Why Is Trust in Health Leadership Eroding? The timing of this survey is particularly significant. It comes as the Department of Health and Human Services faces multiple challenges to its credibility. The FDA's vaccine center chief, Vinay Prasad, is leaving his position in April after a tenure marked by criticism of the agency he was hired to lead. Prasad was known as a critic of the FDA before joining it, and his time at the agency has been shaped by that same critical attitude, affecting morale among career officials and the agency's relationships with outside companies. Additionally, the survey was conducted during a period when HHS leadership has made controversial public health claims. For example, Health and Human Services Secretary Robert F. Kennedy Jr. aggressively promoted leucovorin as a potential autism treatment in the fall, though the drug was never approved for that purpose. The FDA later approved a label change for leucovorin to treat a rare genetic condition, not autism. At the same press conference where Kennedy touted leucovorin, President Donald Trump urged pregnant women not to take Tylenol, despite no scientific evidence linking the medication to autism. How to Evaluate Health Information From Different Sources - Check the Source's Independence: Consider whether the organization providing health information has financial incentives or political motivations that might influence their recommendations. Career scientists and professional medical organizations often have fewer conflicts of interest than political appointees. - Look for Peer Review and Evidence: Health claims should be backed by published research that has been reviewed by other experts in the field. Be skeptical of treatments promoted without this kind of scientific validation. - Verify Claims Through Multiple Channels: If you hear a health claim from a government official, cross-reference it with information from professional medical organizations and peer-reviewed research to ensure accuracy. - Distinguish Between Approved Uses and Promoted Uses: Just because a medication exists does not mean it is approved or effective for treating a particular condition. Always check the FDA-approved uses for any drug before considering it as a treatment option. The Annenberg survey results suggest that the public is paying close attention to these kinds of inconsistencies and questionable health claims. Research shows that after Trump's press conference urging pregnant women to avoid Tylenol, prescriptions for the medication among pregnant people actually declined, indicating that public messaging from high-level officials does influence health decisions. This erosion of trust in health leadership comes at a critical time, as the nation continues to grapple with infectious disease threats and public health challenges. When Americans lose confidence in the officials leading health agencies, it can undermine public health efforts and make it harder to communicate important health information during emergencies. The survey suggests that rebuilding trust will require health leaders to align their public statements with scientific evidence and to demonstrate that they are prioritizing public health over political considerations.
